Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

NCT ID: NCT05428501

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-18

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Person Living with Obesity (PLwO)

PLwO recruited via online platforms or face-to-face channels

no treatment given

Intervention Type OTHER

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Health Care Professionals (HCPs)

HCPs treating people who have obesity

no treatment given

Intervention Type OTHER

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no treatment given

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PLwO:

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, aged above or equal to 18 years at the time of signing informed consent
3. Lives in mainland China and is native Chinese
4. Current BMI based on self-reported height and weight of at least 28 kg/m\^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)

HCPs:

1. Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
2. Male or female, aged greather than or equal to18 years at the time of signing informed consent.
3. Physician with a license to practice
4. Specialty is not surgeon (including general, bariatric or plastic surgeon)
5. Practices in mainland China with at least 5 years in clinical practice
6. Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
7. Has seen at least 100 patients in the past month
8. Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m\^2 with or without comorbidities) in the past month

Exclusion Criteria

PLwO

1\. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs

1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novo Nordisk A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Transparency (dept. 2834)

Role: STUDY_DIRECTOR

Novo Nordisk A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Novo Nordisk Investigational Site

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Ji L, Mu Y, Chang C, Wang H, Zhao D, Liu D, Shen Z, Chen W. Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study. Diabetes Obes Metab. 2024 Oct;26(10):4694-4704. doi: 10.1111/dom.15837. Epub 2024 Aug 9.

Reference Type RESULT
PMID: 39119627 (View on PubMed)

Luo Y, Mu Y, Chen W, Wang H, Zhao D, Liu D, Zhang J, Ji L. Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study. Diabetes Obes Metab. 2025 Jul;27(7):3627-3634. doi: 10.1111/dom.16369. Epub 2025 Apr 15.

Reference Type DERIVED
PMID: 40230237 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1266-4279

Identifier Type: OTHER

Identifier Source: secondary_id

DAS-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

China Health Big Data
NCT03699228 RECRUITING
Obesity and Oral Diseases in Adult Patients
NCT04602572 NOT_YET_RECRUITING